Real-time enrollment status for this prolonged seizures clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 7:54 AM UTC
| NCT Number | NCT05077904 |
| Recruiting Status | Recruiting |
| Condition | Prolonged Seizures |
| Phase | PHASE3 |
| Target Enrollment | 350 participants |
| Active Locations | 66 sites in the US |
| Sponsor | UCB Biopharma SRL |
| Last Updated on CT.gov | July 1, 2026 (2 weeks ago) |
As of July 19, 2026: Clinical trial NCT05077904 is currently recruiting participants. This phase3 study for prolonged seizures is actively seeking new participants at 66 locations across the United States. The study is sponsored by UCB Biopharma SRL. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05077904 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 66 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05077904 was last updated 2 weeks ago (July 1, 2026). HelloStudys verifies this status automatically.